News

As per the agreement, Tecan will industrialise and deliver manufactured ML instruments for Enigma’s global market supplies for an initial five-year contract, and will also manage the ML

Gorbec currently provides complete development, regulatory, analytical, and manufacturing services for US-based customers. The company’s future plans call for an increased capacity to develop and submit New Drug

Together with many other pharmaceutical manufacturers, Teva is named in numerous civil lawsuits that relate to drug price reporting by manufacturers in about 15 states. The cases, which

The clinical candidate is a new class of agent containing three separate RNAi elements, simultaneously targeting three different sites of the hepatitis C virus, and encapsidated in an

Earlier, on April 16, 2008, Pfizer and Celldex Therapeutics (Celldex) have entered into an agreement to grant Pfizer an exclusive worldwide license to PF-04948568 (CDX-110) which is currently

In the clinical study, children aged 7-11 years with EPI due to CF experienced an improved coefficient of fat absorption (CFA) during treatment with Creon, as compared to

Based on the results of pre-clinical and clinical trials conducted by SanBio, Teijin plans to begin clinical trials in Japan. SanBio developed SB623 by processing bone marrow from

The orphan drug designation potentially may provide AVI up to ten years of market exclusivity, if the drug candidate is approved for marketing in the EU. AVI-4658, another

Preliminary clinical data from the first 24 weeks of the study (12 weeks at 0.1mg/kg and 12 weeks at 1.0mg/kg) have been evaluated. BioMarin plans to announce top-line